LKFT
Lakefront BiotherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
Current thesis
Composite grade D from latest DB weights. Momentum 26.6 / Value 57.0
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -2.3.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
27
Value
57
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-21
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $32.37
Why
Momentum27 · Δ7d -7.3
Value57 · Δ7d -2.3
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
27
40% active weight
Current posture
7d trendSoftening
Δ7d
-7.3
Δ21d
-9.9
Value
57
60% active weight
Current posture
7d trendSoftening
Δ7d
-2.3
Δ21d
-2.5
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 26.6 / Value 57.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.92B
Beta
-0.29
Shares Out
65.9M
P/E (TTM) · Derived
5.3
P/S (TTM)
6.27
P/FCF (TTM) · Derived
-6.63
Rev YoY
-90.4%
EPS YoY
-110.5%
Gross Margin
+98.0%
Op Margin
-182.9%
Net Debt
-$3.51B
Current Ratio
30.48
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology